Recombinant antibodies to human interkleukin-1 beta

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 37/00 (2006.01) A61P 43/00 (2006.01) C07K 16/24 (2006.01) C07K 16/46 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2396212

An IL-1.beta. binding molecule, in particular an antibody to human IL-1.beta., especially a human antibody to human IL-1.beta. is provided, wherein the CDRs of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritides.

L'invention concerne une molécule de liaison d'interleukine 1.beta., notamment un anticorps anti-interleukine 1.beta. humain, plus spécifiquement un anticorps humain anti-interleukine 1.beta., les régions hypervariables des chaînes légères et lourdes renfermant des séquences d'acides aminés comme défini. Cette molécule est utilisée dans le traitement d'une maladie ou d'un trouble à médiation par interleukine-1, par exemple, l'ostéo-arthrite, l'ostéoporose et autres types d'arthrite inflammatoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant antibodies to human interkleukin-1 beta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant antibodies to human interkleukin-1 beta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant antibodies to human interkleukin-1 beta will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2015294

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.